APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Coagulation Factor Concentrate

Compare research editions
View pricing & licenses

Selected research

Industry Research

Recombinant Coagulation Factor Concentrate Industry Research Report 2026

Report ID 174031290529 December 2025145 pages

Choose your research edition.

Industry ResearchRecombinant Coagulation Factor Concentrate Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Coagulation Factor Concentrate Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Recombinant Coagulation Factor Concentrate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Coagulation Factor Concentrate Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant Coagulation Factor Concentrate Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Recombinant Coagulation Factor Concentrate market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Recombinant Coagulation Factor Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Recombinant Coagulation Factor Concentrate is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Recombinant Coagulation Factor Concentrate is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Recombinant Coagulation Factor Concentrate include Baxalta, Benefix, Idelvion, Lxinity, Novo Disk, Rebinyn, Rixubis, Biogen and Baxter, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Recombinant Coagulation Factor Concentrate market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Recombinant Coagulation Factor Concentrate Market by Company

Baxalta

Benefix

Idelvion

Lxinity

Novo Disk

Rebinyn

Rixubis

Biogen

Baxter

Bayer

Beijing Tiantan Biological Products

HUALAN BIOLOGICAL ENGINEERING

Pfizer

Wyeth

CSL

Green Cross

Alprolix

Sanofi

SHANGHAI RAAS

Taibang Biologic Group

Recombinant Coagulation Factor Concentrate Segment by Type

500IU

250IU

2000IU

1000IU

Recombinant Coagulation Factor Concentrate Segment by Application

Hopistial

Clinic

Others

Recombinant Coagulation Factor Concentrate Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Coagulation Factor Concentrate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Coagulation Factor Concentrate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Coagulation Factor Concentrate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Recombinant Coagulation Factor Concentrate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Recombinant Coagulation Factor Concentrate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Recombinant Coagulation Factor Concentrate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Recombinant Coagulation Factor Concentrate Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Recombinant Coagulation Factor Concentrate Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Manufacturers (2021-2026) Table 8. Global Recombinant Coagulation Factor Concentrate Revenue of Manufacturers (2021-2026) Table 9. Global Recombinant Coagulation Factor Concentrate Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Recombinant Coagulation Factor Concentrate Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Recombinant Coagulation Factor Concentrate Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Recombinant Coagulation Factor Concentrate, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Recombinant Coagulation Factor Concentrate, Product Type & Application Table 14. Global Recombinant Coagulation Factor Concentrate Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Recombinant Coagulation Factor Concentrate by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Baxalta Company Information Table 19. Baxalta Business Overview Table 20. Baxalta Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Baxalta Recombinant Coagulation Factor Concentrate Product Portfolio Table 22. Baxalta Recent Developments Table 23. Benefix Company Information Table 24. Benefix Business Overview Table 25. Benefix Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Benefix Recombinant Coagulation Factor Concentrate Product Portfolio Table 27. Benefix Recent Developments Table 28. Idelvion Company Information Table 29. Idelvion Business Overview Table 30. Idelvion Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Idelvion Recombinant Coagulation Factor Concentrate Product Portfolio Table 32. Idelvion Recent Developments Table 33. Lxinity Company Information Table 34. Lxinity Business Overview Table 35. Lxinity Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Lxinity Recombinant Coagulation Factor Concentrate Product Portfolio Table 37. Lxinity Recent Developments Table 38. Novo Disk Company Information Table 39. Novo Disk Business Overview Table 40. Novo Disk Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Novo Disk Recombinant Coagulation Factor Concentrate Product Portfolio Table 42. Novo Disk Recent Developments Table 43. Rebinyn Company Information Table 44. Rebinyn Business Overview Table 45. Rebinyn Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Rebinyn Recombinant Coagulation Factor Concentrate Product Portfolio Table 47. Rebinyn Recent Developments Table 48. Rixubis Company Information Table 49. Rixubis Business Overview Table 50. Rixubis Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Rixubis Recombinant Coagulation Factor Concentrate Product Portfolio Table 52. Rixubis Recent Developments Table 53. Biogen Company Information Table 54. Biogen Business Overview Table 55. Biogen Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Biogen Recombinant Coagulation Factor Concentrate Product Portfolio Table 57. Biogen Recent Developments Table 58. Baxter Company Information Table 59. Baxter Business Overview Table 60. Baxter Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Baxter Recombinant Coagulation Factor Concentrate Product Portfolio Table 62. Baxter Recent Developments Table 63. Bayer Company Information Table 64. Bayer Business Overview Table 65. Bayer Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Bayer Recombinant Coagulation Factor Concentrate Product Portfolio Table 67. Bayer Recent Developments Table 68. Beijing Tiantan Biological Products Company Information Table 69. Beijing Tiantan Biological Products Business Overview Table 70. Beijing Tiantan Biological Products Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Beijing Tiantan Biological Products Recombinant Coagulation Factor Concentrate Product Portfolio Table 72. Beijing Tiantan Biological Products Recent Developments Table 73. HUALAN BIOLOGICAL ENGINEERING Company Information Table 74. HUALAN BIOLOGICAL ENGINEERING Business Overview Table 75. HUALAN BIOLOGICAL ENGINEERING Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. HUALAN BIOLOGICAL ENGINEERING Recombinant Coagulation Factor Concentrate Product Portfolio Table 77. HUALAN BIOLOGICAL ENGINEERING Recent Developments Table 78. Pfizer Company Information Table 79. Pfizer Business Overview Table 80. Pfizer Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Pfizer Recombinant Coagulation Factor Concentrate Product Portfolio Table 82. Pfizer Recent Developments Table 83. Wyeth Company Information Table 84. Wyeth Business Overview Table 85. Wyeth Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Wyeth Recombinant Coagulation Factor Concentrate Product Portfolio Table 87. Wyeth Recent Developments Table 88. CSL Company Information Table 89. CSL Business Overview Table 90. CSL Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. CSL Recombinant Coagulation Factor Concentrate Product Portfolio Table 92. CSL Recent Developments Table 93. Green Cross Company Information Table 94. Green Cross Business Overview Table 95. Green Cross Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Green Cross Recombinant Coagulation Factor Concentrate Product Portfolio Table 97. Green Cross Recent Developments Table 98. Alprolix Company Information Table 99. Alprolix Business Overview Table 100. Alprolix Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Alprolix Recombinant Coagulation Factor Concentrate Product Portfolio Table 102. Alprolix Recent Developments Table 103. Sanofi Company Information Table 104. Sanofi Business Overview Table 105. Sanofi Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Sanofi Recombinant Coagulation Factor Concentrate Product Portfolio Table 107. Sanofi Recent Developments Table 108. SHANGHAI RAAS Company Information Table 109. SHANGHAI RAAS Business Overview Table 110. SHANGHAI RAAS Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. SHANGHAI RAAS Recombinant Coagulation Factor Concentrate Product Portfolio Table 112. SHANGHAI RAAS Recent Developments Table 113. Taibang Biologic Group Company Information Table 114. Taibang Biologic Group Business Overview Table 115. Taibang Biologic Group Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Taibang Biologic Group Recombinant Coagulation Factor Concentrate Product Portfolio Table 117. Taibang Biologic Group Recent Developments Table 118. Global Recombinant Coagulation Factor Concentrate Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 119. Global Recombinant Coagulation Factor Concentrate Sales by Region (2021-2026) & (K Units) Table 120. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Region (2021-2026) Table 121. Global Recombinant Coagulation Factor Concentrate Sales by Region (2027-2032) & (K Units) Table 122. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Region (2027-2032) Table 123. Global Recombinant Coagulation Factor Concentrate Revenue by Region (2021-2026) & (US$ Million) Table 124. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Region (2021-2026) Table 125. Global Recombinant Coagulation Factor Concentrate Revenue by Region (2027-2032) & (US$ Million) Table 126. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Region (2027-2032) Table 127. North America Recombinant Coagulation Factor Concentrate Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. North America Recombinant Coagulation Factor Concentrate Sales by Country (2021-2026) & (K Units) Table 129. North America Recombinant Coagulation Factor Concentrate Sales by Country (2027-2032) & (K Units) Table 130. North America Recombinant Coagulation Factor Concentrate Revenue by Country (2021-2026) & (US$ Million) Table 131. North America Recombinant Coagulation Factor Concentrate Revenue by Country (2027-2032) & (US$ Million) Table 132. Europe Recombinant Coagulation Factor Concentrate Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Europe Recombinant Coagulation Factor Concentrate Sales by Country (2021-2026) & (K Units) Table 134. Europe Recombinant Coagulation Factor Concentrate Sales by Country (2027-2032) & (K Units) Table 135. Europe Recombinant Coagulation Factor Concentrate Revenue by Country (2021-2026) & (US$ Million) Table 136. Europe Recombinant Coagulation Factor Concentrate Revenue by Country (2027-2032) & (US$ Million) Table 137. Asia Pacific Recombinant Coagulation Factor Concentrate Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Asia Pacific Recombinant Coagulation Factor Concentrate Sales by Country (2021-2026) & (K Units) Table 139. Asia Pacific Recombinant Coagulation Factor Concentrate Sales by Country (2027-2032) & (K Units) Table 140. Asia Pacific Recombinant Coagulation Factor Concentrate Revenue by Country (2021-2026) & (US$ Million) Table 141. Asia Pacific Recombinant Coagulation Factor Concentrate Revenue by Country (2027-2032) & (US$ Million) Table 142. South America Recombinant Coagulation Factor Concentrate Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. South America Recombinant Coagulation Factor Concentrate Sales by Country (2021-2026) & (K Units) Table 144. South America Recombinant Coagulation Factor Concentrate Sales by Country (2027-2032) & (K Units) Table 145. South America Recombinant Coagulation Factor Concentrate Revenue by Country (2021-2026) & (US$ Million) Table 146. South America Recombinant Coagulation Factor Concentrate Revenue by Country (2027-2032) & (US$ Million) Table 147. Middle East and Africa Recombinant Coagulation Factor Concentrate Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. Middle East and Africa Recombinant Coagulation Factor Concentrate Sales by Country (2021-2026) & (K Units) Table 149. Middle East and Africa Recombinant Coagulation Factor Concentrate Sales by Country (2027-2032) & (K Units) Table 150. Middle East and Africa Recombinant Coagulation Factor Concentrate Revenue by Country (2021-2026) & (US$ Million) Table 151. Middle East and Africa Recombinant Coagulation Factor Concentrate Revenue by Country (2027-2032) & (US$ Million) Table 152. Global Recombinant Coagulation Factor Concentrate Sales by Type (2021-2026) & (K Units) Table 153. Global Recombinant Coagulation Factor Concentrate Sales by Type (2027-2032) & (K Units) Table 154. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Type (2021-2026) Table 155. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Type (2027-2032) Table 156. Global Recombinant Coagulation Factor Concentrate Revenue by Type (2021-2026) & (US$ Million) Table 157. Global Recombinant Coagulation Factor Concentrate Revenue by Type (2027-2032) & (US$ Million) Table 158. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Type (2021-2026) Table 159. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Type (2027-2032) Table 160. Global Recombinant Coagulation Factor Concentrate Price by Type (2021-2026) & (US$/Unit) Table 161. Global Recombinant Coagulation Factor Concentrate Price by Type (2027-2032) & (US$/Unit) Table 162. Global Recombinant Coagulation Factor Concentrate Sales by Application (2021-2026) & (K Units) Table 163. Global Recombinant Coagulation Factor Concentrate Sales by Application (2027-2032) & (K Units) Table 164. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Application (2021-2026) Table 165. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Application (2027-2032) Table 166. Global Recombinant Coagulation Factor Concentrate Revenue by Application (2021-2026) & (US$ Million) Table 167. Global Recombinant Coagulation Factor Concentrate Revenue by Application (2027-2032) & (US$ Million) Table 168. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Application (2021-2026) Table 169. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Application (2027-2032) Table 170. Global Recombinant Coagulation Factor Concentrate Price by Application (2021-2026) & (US$/Unit) Table 171. Global Recombinant Coagulation Factor Concentrate Price by Application (2027-2032) & (US$/Unit) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Recombinant Coagulation Factor Concentrate Distributors List Table 175. Recombinant Coagulation Factor Concentrate Customers List Table 176. Recombinant Coagulation Factor Concentrate Industry Trends Table 177. Recombinant Coagulation Factor Concentrate Industry Drivers Table 178. Recombinant Coagulation Factor Concentrate Industry Restraints Table 179. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Recombinant Coagulation Factor Concentrate Product Image Figure 5. Global Recombinant Coagulation Factor Concentrate Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Recombinant Coagulation Factor Concentrate Market Size (2021-2032) & (US$ Million) Figure 7. Global Recombinant Coagulation Factor Concentrate Sales (2021-2032) & (K Units) Figure 8. Global Recombinant Coagulation Factor Concentrate Average Price (US$/Unit) & (2021-2032) Figure 9. 500IU Product Image Figure 10. 250IU Product Image Figure 11. 2000IU Product Image Figure 12. 1000IU Product Image Figure 13. Hopistial Product Image Figure 14. Clinic Product Image Figure 15. Others Product Image Figure 16. Global Recombinant Coagulation Factor Concentrate Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Recombinant Coagulation Factor Concentrate, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Recombinant Coagulation Factor Concentrate Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Recombinant Coagulation Factor Concentrate Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Recombinant Coagulation Factor Concentrate Sales by Region in 2025 Figure 22. Global Recombinant Coagulation Factor Concentrate Revenue by Region in 2025 Figure 23. North America Recombinant Coagulation Factor Concentrate Market Size by Country in 2025 Figure 24. North America Recombinant Coagulation Factor Concentrate Sales Market Share by Country (2021-2032) Figure 25. North America Recombinant Coagulation Factor Concentrate Revenue Market Share by Country (2021-2032) Figure 26. United States Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Recombinant Coagulation Factor Concentrate Market Size by Country in 2025 Figure 29. Europe Recombinant Coagulation Factor Concentrate Sales Market Share by Country (2021-2032) Figure 30. Europe Recombinant Coagulation Factor Concentrate Revenue Market Share by Country (2021-2032) Figure 31. Germany Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Netherlands Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Asia Pacific Recombinant Coagulation Factor Concentrate Market Size by Country in 2025 Figure 37. Asia Pacific Recombinant Coagulation Factor Concentrate Sales Market Share by Country (2021-2032) Figure 38. Asia Pacific Recombinant Coagulation Factor Concentrate Revenue Market Share by Country (2021-2032) Figure 39. China Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Japan Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. South Korea Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. India Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Australia Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. China Taiwan Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Southeast Asia Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Southeast Asia Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South America Recombinant Coagulation Factor Concentrate Market Size by Country in 2025 Figure 48. South America Recombinant Coagulation Factor Concentrate Sales Market Share by Country (2021-2032) Figure 49. South America Recombinant Coagulation Factor Concentrate Revenue Market Share by Country (2021-2032) Figure 50. Mexico Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Brazil Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Argentina Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Middle East and Africa Recombinant Coagulation Factor Concentrate Market Size by Country in 2025 Figure 54. Middle East and Africa Recombinant Coagulation Factor Concentrate Sales Market Share by Country (2021-2032) Figure 55. Middle East and Africa Recombinant Coagulation Factor Concentrate Revenue Market Share by Country (2021-2032) Figure 56. Turkey Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Saudi Arabia Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. UAE Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Type (2021-2032) Figure 60. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Type (2021-2032) Figure 61. Global Recombinant Coagulation Factor Concentrate Price (US$/Unit) by Type (2021-2032) Figure 62. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Application (2021-2032) Figure 63. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Application (2021-2032) Figure 64. Global Recombinant Coagulation Factor Concentrate Price (US$/Unit) by Application (2021-2032) Figure 65. Recombinant Coagulation Factor Concentrate Value Chain Figure 66. Recombinant Coagulation Factor Concentrate Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Recombinant Coagulation Factor Concentrate Industry Opportunities and Challenges

Scope & coverage.

Types
  • 500IU
  • 250IU
  • 2000IU
  • 1000IU
Applications
  • Hopistial
  • Clinic
  • Others
Companies covered
  • Baxalta
  • Benefix
  • Idelvion
  • Lxinity
  • Novo Disk
  • Rebinyn
  • Rixubis
  • Biogen
  • Baxter
  • Bayer
  • Beijing Tiantan Biological Products
  • HUALAN BIOLOGICAL ENGINEERING
  • Pfizer
  • Wyeth
  • CSL
  • Green Cross
  • Alprolix
  • Sanofi
  • SHANGHAI RAAS
  • Taibang Biologic Group

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Recombinant Coagulation Factor Concentrate Market Size (2021-2032)
  4. 2.2.2 Global Recombinant Coagulation Factor Concentrate Sales (2021-2032)
  5. 2.2.3 Global Recombinant Coagulation Factor Concentrate Market Average Price (2021-2032)
  6. 2.3 Recombinant Coagulation Factor Concentrate by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 500IU
  9. 2.3.3 250IU
  10. 2.3.4 2000IU
  11. 2.3.5 1000IU
  12. 2.4 Recombinant Coagulation Factor Concentrate by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Hopistial
  15. 2.4.3 Clinic
  16. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Recombinant Coagulation Factor Concentrate Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Recombinant Coagulation Factor Concentrate Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Recombinant Coagulation Factor Concentrate Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Recombinant Coagulation Factor Concentrate Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Recombinant Coagulation Factor Concentrate Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Recombinant Coagulation Factor Concentrate, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Recombinant Coagulation Factor Concentrate, Product Type & Application
  8. 3.8 Global Manufacturers of Recombinant Coagulation Factor Concentrate, Established Date
  9. 3.9 Global Recombinant Coagulation Factor Concentrate Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Baxalta
  2. 4.1.1 Baxalta Company Information
  3. 4.1.2 Baxalta Business Overview
  4. 4.1.3 Baxalta Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Baxalta Recombinant Coagulation Factor Concentrate Product Portfolio
  6. 4.1.5 Baxalta Recent Developments
  7. 4.2 Benefix
  8. 4.2.1 Benefix Company Information
  9. 4.2.2 Benefix Business Overview
  10. 4.2.3 Benefix Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Benefix Recombinant Coagulation Factor Concentrate Product Portfolio
  12. 4.2.5 Benefix Recent Developments
  13. 4.3 Idelvion
  14. 4.3.1 Idelvion Company Information
  15. 4.3.2 Idelvion Business Overview
  16. 4.3.3 Idelvion Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Idelvion Recombinant Coagulation Factor Concentrate Product Portfolio
  18. 4.3.5 Idelvion Recent Developments
  19. 4.4 Lxinity
  20. 4.4.1 Lxinity Company Information
  21. 4.4.2 Lxinity Business Overview
  22. 4.4.3 Lxinity Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Lxinity Recombinant Coagulation Factor Concentrate Product Portfolio
  24. 4.4.5 Lxinity Recent Developments
  25. 4.5 Novo Disk
  26. 4.5.1 Novo Disk Company Information
  27. 4.5.2 Novo Disk Business Overview
  28. 4.5.3 Novo Disk Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Novo Disk Recombinant Coagulation Factor Concentrate Product Portfolio
  30. 4.5.5 Novo Disk Recent Developments
  31. 4.6 Rebinyn
  32. 4.6.1 Rebinyn Company Information
  33. 4.6.2 Rebinyn Business Overview
  34. 4.6.3 Rebinyn Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Rebinyn Recombinant Coagulation Factor Concentrate Product Portfolio
  36. 4.6.5 Rebinyn Recent Developments
  37. 4.7 Rixubis
  38. 4.7.1 Rixubis Company Information
  39. 4.7.2 Rixubis Business Overview
  40. 4.7.3 Rixubis Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Rixubis Recombinant Coagulation Factor Concentrate Product Portfolio
  42. 4.7.5 Rixubis Recent Developments
  43. 4.8 Biogen
  44. 4.8.1 Biogen Company Information
  45. 4.8.2 Biogen Business Overview
  46. 4.8.3 Biogen Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Biogen Recombinant Coagulation Factor Concentrate Product Portfolio
  48. 4.8.5 Biogen Recent Developments
  49. 4.9 Baxter
  50. 4.9.1 Baxter Company Information
  51. 4.9.2 Baxter Business Overview
  52. 4.9.3 Baxter Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Baxter Recombinant Coagulation Factor Concentrate Product Portfolio
  54. 4.9.5 Baxter Recent Developments
  55. 4.10 Bayer
  56. 4.10.1 Bayer Company Information
  57. 4.10.2 Bayer Business Overview
  58. 4.10.3 Bayer Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Bayer Recombinant Coagulation Factor Concentrate Product Portfolio
  60. 4.10.5 Bayer Recent Developments
  61. 4.11 Beijing Tiantan Biological Products
  62. 4.11.1 Beijing Tiantan Biological Products Company Information
  63. 4.11.2 Beijing Tiantan Biological Products Business Overview
  64. 4.11.3 Beijing Tiantan Biological Products Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Beijing Tiantan Biological Products Recombinant Coagulation Factor Concentrate Product Portfolio
  66. 4.11.5 Beijing Tiantan Biological Products Recent Developments
  67. 4.12 HUALAN BIOLOGICAL ENGINEERING
  68. 4.12.1 HUALAN BIOLOGICAL ENGINEERING Company Information
  69. 4.12.2 HUALAN BIOLOGICAL ENGINEERING Business Overview
  70. 4.12.3 HUALAN BIOLOGICAL ENGINEERING Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 HUALAN BIOLOGICAL ENGINEERING Recombinant Coagulation Factor Concentrate Product Portfolio
  72. 4.12.5 HUALAN BIOLOGICAL ENGINEERING Recent Developments
  73. 4.13 Pfizer
  74. 4.13.1 Pfizer Company Information
  75. 4.13.2 Pfizer Business Overview
  76. 4.13.3 Pfizer Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Pfizer Recombinant Coagulation Factor Concentrate Product Portfolio
  78. 4.13.5 Pfizer Recent Developments
  79. 4.14 Wyeth
  80. 4.14.1 Wyeth Company Information
  81. 4.14.2 Wyeth Business Overview
  82. 4.14.3 Wyeth Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Wyeth Recombinant Coagulation Factor Concentrate Product Portfolio
  84. 4.14.5 Wyeth Recent Developments
  85. 4.15 CSL
  86. 4.15.1 CSL Company Information
  87. 4.15.2 CSL Business Overview
  88. 4.15.3 CSL Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 CSL Recombinant Coagulation Factor Concentrate Product Portfolio
  90. 4.15.5 CSL Recent Developments
  91. 4.16 Green Cross
  92. 4.16.1 Green Cross Company Information
  93. 4.16.2 Green Cross Business Overview
  94. 4.16.3 Green Cross Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Green Cross Recombinant Coagulation Factor Concentrate Product Portfolio
  96. 4.16.5 Green Cross Recent Developments
  97. 4.17 Alprolix
  98. 4.17.1 Alprolix Company Information
  99. 4.17.2 Alprolix Business Overview
  100. 4.17.3 Alprolix Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Alprolix Recombinant Coagulation Factor Concentrate Product Portfolio
  102. 4.17.5 Alprolix Recent Developments
  103. 4.18 Sanofi
  104. 4.18.1 Sanofi Company Information
  105. 4.18.2 Sanofi Business Overview
  106. 4.18.3 Sanofi Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Sanofi Recombinant Coagulation Factor Concentrate Product Portfolio
  108. 4.18.5 Sanofi Recent Developments
  109. 4.19 SHANGHAI RAAS
  110. 4.19.1 SHANGHAI RAAS Company Information
  111. 4.19.2 SHANGHAI RAAS Business Overview
  112. 4.19.3 SHANGHAI RAAS Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 SHANGHAI RAAS Recombinant Coagulation Factor Concentrate Product Portfolio
  114. 4.19.5 SHANGHAI RAAS Recent Developments
  115. 4.20 Taibang Biologic Group
  116. 4.20.1 Taibang Biologic Group Company Information
  117. 4.20.2 Taibang Biologic Group Business Overview
  118. 4.20.3 Taibang Biologic Group Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Taibang Biologic Group Recombinant Coagulation Factor Concentrate Product Portfolio
  120. 4.20.5 Taibang Biologic Group Recent Developments
5 Global Recombinant Coagulation Factor Concentrate Market Scenario by Region
  1. 5.1 Global Recombinant Coagulation Factor Concentrate Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Recombinant Coagulation Factor Concentrate Sales by Region: 2021-2032
  3. 5.2.1 Global Recombinant Coagulation Factor Concentrate Sales by Region: 2021-2026
  4. 5.2.2 Global Recombinant Coagulation Factor Concentrate Sales by Region: 2027-2032
  5. 5.3 Global Recombinant Coagulation Factor Concentrate Revenue by Region: 2021-2032
  6. 5.3.1 Global Recombinant Coagulation Factor Concentrate Revenue by Region: 2021-2026
  7. 5.3.2 Global Recombinant Coagulation Factor Concentrate Revenue by Region: 2027-2032
  8. 5.4 North America Recombinant Coagulation Factor Concentrate Market Facts & Figures by Country
  9. 5.4.1 North America Recombinant Coagulation Factor Concentrate Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Recombinant Coagulation Factor Concentrate Sales by Country (2021-2032)
  11. 5.4.3 North America Recombinant Coagulation Factor Concentrate Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Recombinant Coagulation Factor Concentrate Market Facts & Figures by Country
  15. 5.5.1 Europe Recombinant Coagulation Factor Concentrate Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Recombinant Coagulation Factor Concentrate Sales by Country (2021-2032)
  17. 5.5.3 Europe Recombinant Coagulation Factor Concentrate Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Recombinant Coagulation Factor Concentrate Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Recombinant Coagulation Factor Concentrate Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Recombinant Coagulation Factor Concentrate Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Recombinant Coagulation Factor Concentrate Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Recombinant Coagulation Factor Concentrate Market Facts & Figures by Country
  35. 5.7.1 South America Recombinant Coagulation Factor Concentrate Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Recombinant Coagulation Factor Concentrate Sales by Country (2021-2032)
  37. 5.7.3 South America Recombinant Coagulation Factor Concentrate Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Recombinant Coagulation Factor Concentrate Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Recombinant Coagulation Factor Concentrate Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Recombinant Coagulation Factor Concentrate Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Recombinant Coagulation Factor Concentrate Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Recombinant Coagulation Factor Concentrate Sales by Type (2021-2032)
  2. 6.1.1 Global Recombinant Coagulation Factor Concentrate Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Recombinant Coagulation Factor Concentrate Sales Market Share by Type (2021-2032)
  4. 6.2 Global Recombinant Coagulation Factor Concentrate Revenue by Type (2021-2032)
  5. 6.2.1 Global Recombinant Coagulation Factor Concentrate Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Recombinant Coagulation Factor Concentrate Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Recombinant Coagulation Factor Concentrate Sales by Application (2021-2032)
  2. 7.1.1 Global Recombinant Coagulation Factor Concentrate Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Recombinant Coagulation Factor Concentrate Sales Market Share by Application (2021-2032)
  4. 7.2 Global Recombinant Coagulation Factor Concentrate Revenue by Application (2021-2032)
  5. 7.2.1 Global Recombinant Coagulation Factor Concentrate Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Recombinant Coagulation Factor Concentrate Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Recombinant Coagulation Factor Concentrate Value Chain Analysis
  2. 8.1.1 Recombinant Coagulation Factor Concentrate Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Recombinant Coagulation Factor Concentrate Production Mode & Process
  5. 8.2 Recombinant Coagulation Factor Concentrate Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Recombinant Coagulation Factor Concentrate Distributors
  8. 8.2.3 Recombinant Coagulation Factor Concentrate Customers
9 Global Recombinant Coagulation Factor Concentrate Analyzing Market Dynamics
  1. 9.1 Recombinant Coagulation Factor Concentrate Industry Trends
  2. 9.2 Recombinant Coagulation Factor Concentrate Industry Drivers
  3. 9.3 Recombinant Coagulation Factor Concentrate Industry Opportunities and Challenges
  4. 9.4 Recombinant Coagulation Factor Concentrate Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst